From: Liver saturated fat content associates with hepatic DNA methylation in obese individuals
 | Normal liver | SS | NASH | p valuea |
---|---|---|---|---|
Total, n | 24 | 12 | 15 | – |
Men/Women, n | 8/16 | 5/7 | 6/9 | n.s. |
Age (years) | 49.6 ± 8.3 | 47.3 ± 8.2 | 50.3 ± 9.2 | n.s. |
BMI (Kg/m2) | 43.0 ± 6.3 | 44.4 ± 5.5 | 44.1 ± 6.6 | n.s. |
fS-Total cholesterol (mmol/L) | 4.1 ± 0.7 | 4.0 ± 0.9 | 4.1 ± 0.9 | n.s. |
fS-LDL-c (mmol/L) | 2.4 ± 0.7 | 2.1 ± 0.7 | 2.4 ± 0.7 | n.s. |
fS-HDL-c (mmol/L) | 1.0 ± 0.2 | 0.9 ± 0.1 | 1.0 ± 0.2 | n.s. |
fS-TG (mmol/L) | 1.2 (1.0–1.6) | 1.8 (1.3–2.3)* | 1.3 (1.0–1.9) | 0.027 |
fP-Glucose (mmol/L) | 5.8 ± 0.6 | 6.0 ± 1.2 | 6.7 ± 1.6 | n.s. |
fS-Insulin (mU/L) | 12.9 (7.6–19.2) | 14.9 (10.0–21.8) | 15.8 (12.6–28)* | 0.041 |
Type 2 diabetes (N/Y), n | 18/6 | 6/6 | 6/9 | n.s. |
Total liver SFA content | 61.7 ± 19.7 | 101.0 ± 34.2* | 123.9 ± 65.5* | 0.00002 |